BioSpace News Archive

Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended December 1, 2018.

Faruqi & Faruqi, LLP, reminds investors in Nobilis Health Corp. of the February 12, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

New Rhein Healthcare Investors, an international private equity firm focused on healthcare therapeutics and medical devices, announced today the first closing of its inaugural pooled fund.

Today, AB InBev, the world’s leading brewer, and Tilray, a global pioneer in cannabis production and distribution, announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the High Court of Justice of Antigua and Barbuda rejected the claim of 1Globe Capital LLC (“1Globe”) for a declaration that an alternative slate of directors had been elected at the Company’s Annual General Meeting in February 2018

X-Chem, Inc., announced the signing of a broad strategic drug discovery collaboration with Bristol-Myers Squibb.

Cloudbreak Health, LLC (“Cloudbreak”), leading unified telemedicine solutions provider, today announced they have once again been recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine’s Entrepreneur360™ List, a premier study delivering the most comprehensive analysis of private companies in America.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal first quarter 2019 earnings conference call and webcast on Friday, January 25, 2019, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET).

Varian (NYSE: VAR) today announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco, scheduled for 9:30 a.m. Pacific Time on January 7, 2019.